Iatrogenic Kaposi's sarcoma in a myelofibrosis patient treated with ruxolitinib: Case‐report , literature review, and French pharmacovigilance data-Reference-Cited by-同舟云学术

Iatrogenic Kaposi's sarcoma in a myelofibrosis patient treated with ruxolitinib: Case‐report , literature review, and French pharmacovigilance data

Author:

Moutel Marin¹,Noel Violaine¹,Jary Aude²,Le Quoc‐Hung³,Lier Clément⁴,Viguier Manuelle⁵,Lebbe Céleste⁶,Azzouz Brahim⁷,Bani‐Sadr Firouzé¹⁸^ORCID

Affiliation:

1. Department of Internal Medicine, Infectious Diseases, and Clinical Immunology Reims University Hospital Reims France

2. Department of Virology, Hôpital Pitié Salpêtrière Assistance Publique des Hôpitaux de Paris Paris France

3. Department of Hematology Reims University Hospital Reims France

4. Department of Virology Reims University Hospital Reims France

5. Department of Dermatology Reims University Hospital Reims France

6. Department of Dermatology, Hôpital Saint Louis Assistance Publique des Hôpitaux de Paris Paris France

7. Regional Centre for Pharmacovigilance and Pharmacoepidemiology Reims University Hospital Reims France

8. University of Reims Champagne‐Ardenne Reims France

Publisher

Wiley

Subject

Hematology

Link

Reference6 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Ruxolitinib;Reactions Weekly;2022-06